James B. Bucher - 21 Dec 2023 Form 4 Insider Report for Harpoon Therapeutics, Inc.

Role
Chief Legal Officer
Signature
/s/ James B. Bucher
Issuer symbol
N/A
Transactions as of
21 Dec 2023
Net transactions value
$0
Form type
4
Filing time
26 Dec 2023, 16:10:05 UTC
Previous filing
02 Nov 2022
Next filing
11 Mar 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HARP Employee Stock Option (Right to Buy) Award $0 +110,000 $0.000000 110,000 21 Dec 2023 Common Stock 110,000 $11.30 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the total number of shares subject to the stock option shall vest and become exercisable on the first anniversary of December 21, 2023, and the remainder vests in 36 substantially equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.